Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals [Phase 1]

View source ↗

Summary

This Phase 1 study assessed the interaction between vanoxerine (GBR 12909) and cocaine in cocaine-dependent individuals and was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cocaine (cocaine)
  • Vanoxerine (GBR 12909) (vanoxerine)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine Abuse, Cocaine-Related Disorders | Phase 1 | Status: TERMINATED